Prognostic Value of Erythropoietin (Epo), Soluble Erythropoietin Receptor (sEpoR) and Hematological Parameters in Patients with Head and Neck Cancer (HNC) Treated with Radio- or Radio-Chemotherapy.

Mrochem-Kwarciak J. J.; Rutkowski T.; Wygoda A.; Chmura A.; Deja R.; Kentnowski M.; Brewczynski A.; Skadowski K.

首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Prognostic Value of Erythropoietin (Epo), Soluble Erythropoietin Receptor (sEpoR) and Hematological Parameters in Patients with Head and Neck Cancer (HNC) Treated with Radio- or Radio-Chemotherapy.

【24h】

Prognostic Value of Erythropoietin (Epo), Soluble Erythropoietin Receptor (sEpoR) and Hematological Parameters in Patients with Head and Neck Cancer (HNC) Treated with Radio- or Radio-Chemotherapy.

机译：红细胞癌（HNC）促红细胞生成素（EPO），可溶性促红细胞素受体（SEPOR）和血液学参数用无线电或无线电化疗处理的患者血液学参数。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International Journal of Radiation Oncology, Biology, Physics》 |2019年第1suppla期|共1页
作者
Mrochem-Kwarciak J. J.; Rutkowski T.; Wygoda A.; Chmura A.; Deja R.; Kentnowski M.; Brewczynski A.; Skadowski K.;
展开▼
作者单位

Maria Sklodowska Curie Mem Canc Ctr &

Inst Oncol Gliwice Poland;

Maria Sklodowska Curie Mem Canc Ctr &

Inst Oncol Gliwice Poland;

Maria Sklodowska Curie Mem Canc Ctr &

Inst Oncol Gliwice Poland;

Maria Sklodowska Curie Mem Canc Ctr &

Inst Oncol Gliwice Poland;

Maria Sklodowska Curie Mem Canc Ctr &

Inst Oncol Gliwice Poland;

Maria Sklodowska Curie Canc Ctr Inst Oncol Gliwice Poland;

Maria Sklodowska Curie Mem Canc Ctr &

Inst Oncol Gliwice Poland;

Maria Sklodowska Curie Mem Canc Ctr &

Inst Oncol Gliwice Poland;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. Prognostic Value of Erythropoietin (Epo), Soluble Erythropoietin Receptor (sEpoR) and Hematological Parameters in Patients with Head and Neck Cancer (HNC) Treated with Radio- or Radio-Chemotherapy. [J] . Mrochem-Kwarciak J. J., Rutkowski T., Wygoda A., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：红细胞癌（HNC）促红细胞生成素（EPO），可溶性促红细胞素受体（SEPOR）和血液学参数用无线电或无线电化疗处理的患者血液学参数。
2. Study of efficacy of erythropoietin (epolyrec?) on hematologic parameters in patients with chemotherapy induced anemia and its comparison with erythropoietin (eprex ?) [J] . Panahi M. Abbasinazari M. Tavakoli Ardakani M. Sistanizad Z. Sahraee Y. Research in Pharmaceutical Sciences . 2012,第5期

机译：促红细胞生成素（epolyrec？）对化疗性贫血患者血液学参数的疗效研究及其与促红细胞生成素（eprex®）的比较
3. The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation. [J] . Rades D, Golke H, Schild SE, International Journal of Radiation Oncology, Biology, Physics . 2008,第1期

机译：促红细胞生成素受体和促红细胞生成素的肿瘤表达对化学放疗食管癌患者临床结局的影响。
4. Methodology and technology for the development of a prognostic MRI-based radiomic model for the outcome of head and neck cancer patients [C] . Marco Bologna, Valentina Corino, Chiara Tenconi, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2020

机译：头颈癌患者预后基于MRI的放射学模型开发方法和技术
5. National and Institutional Outcomes Data in Head and Neck Cancers, and Functional and Patient Reported Outcomes in Patients with Oropharyngeal Cancers. [D] . Kansal, Ankit. 2017

机译：头颈癌的国家和机构结局数据，以及口咽癌患者的功能和患者报告结局。
6. The endogenous erythropoietin in correlation with other erythrocytic parameters in patients with head and neck squamous cell carcinoma treated with platinum-based induction chemotherapy [O] . Dominika Leś, Maria Saduś-Wojciechowska, Tomasz Rutkowski, 2019

机译：铂类诱导化疗治疗的头颈部鳞状细胞癌患者内源性促红细胞生成素与其他红细胞参数的关系
7. Prognostic Value of Erythropoietin (Epo), Soluble Erythropoietin Receptor (sEpoR) and Hematological Parameters in Patients with Head and Neck Cancer (HNC) Treated with Radio- or Radio-Chemotherapy. [O] . J.J. Mrochem-Kwarciak, T. Rutkowski, A. Wygoda, 2019

机译：红细胞癌（HNC）促红细胞生成素（EPO），可溶性促红细胞素受体（SEPOR）和血液学参数用无线电或无线电化疗处理的患者血液学参数。

Prognostic Value of Erythropoietin (Epo), Soluble Erythropoietin Receptor (sEpoR) and Hematological Parameters in Patients with Head and Neck Cancer (HNC) Treated with Radio- or Radio-Chemotherapy.

著录项

相似文献

相关主题

期刊订阅